JuanCarlosSalazarMD

Summary

• Juan Carlos Salazar, MD, MPH, is Professor and Chair of Pediatrics at the University of Connecticut School of Medicine and Executive Vice President and Physician-in-chief at Connecticut Children’s.
  
  In addition to serving in these roles, Dr. Salazar has led the Division of Pediatric Infectious Diseases and Immunology at Connecticut Children’s and has been nationally and internationally recognized for both his outstanding clinical care and his innovative research work. Dr. Salazar has received several National Institutes of Health grants to study the human innate immune response to Borrelia burgdorferi and Treponema pallidum, the causative agents of Lyme disease and syphilis respectively. He is currently funded by the NIH to develop a first of its kind syphilis vaccine. The NIH funded U-19 project includes investigators in China, Malawi, Cali, Colombia and the US. Most recently his team received funding from the National Institutes Child Health and Development Institute (NICHD) to study the pathogenesis of COVID-19 and the multi-inflammatory syndrome associated to COVID-19 in children and young adults. He has published over 100 peer reviewed articles and book chapters and has served in multiple scientific review panels at the NIH. He currently serves as a member of the HIBP study section at NIAID (2022-25).
  
  Dr. Salazar also directs the Pediatric and Youth HIV program at the Medical Center. His team has promoted and facilitated regional STD and HIV-prevention programs for at-risk high school youth. Dr. Salazar is the current recipient of three different Ryan White Care Act federal funds to coordinate and provide statewide HIV treatment and prevention services for women, infants, children and youth. He has conducted several NIH and pharmaceutical industry sponsored pediatric and adolescent HIV clinical trials and long-term follow-up studies.
  
  He received his medical degree from the Universidad Javeriana, in Bogota, Colombia, and his MPH from the University of Minne